Combined tests show promise for pulmonary embolism screening
This article was originally published in Clinica
Pulmonary embolism can be ruled out more rapidly, more cheaply and at less risk to the patient, by using a combination of two minimally invasive bedside tests, rather than pulmonary vascular imaging. That is the finding of a multicentre US study.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.